# Dogwood Therapeutics, Inc.: Form 8-K, filed Oct 7, 2024

- Company: [Dogwood Therapeutics, Inc.](/companies/dwtx.md) (CIK 1818844)
- Form: 8-K
- Filed: 2024-10-07
- Accepted by EDGAR: Oct 7, 2024, 08:02 ET
- Period: 2024-10-04
- Accession: 0001558370-24-013167
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1818844/000155837024013167/viri-20241004x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1818844/000155837024013167/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.01: Completion of an acquisition or disposition
- Item 3.02: Unregistered sale of equity
- Item 3.03: Change to security holders’ rights
- Item 5.02: Departure or appointment of officers or directors
- Item 5.03: Amendment to articles or bylaws
- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1818844/000155837024013167/viri-20241004x8k.htm

Filed Oct 7, 2024.
Source: SEC EDGAR, the filing index for accession 0001558370-24-013167. Last ingested by Listed: Oct 30, 2026, 16:07 ET. No prices; not investment advice.